Rivaroxaban

Details

Files

Generic Name:

Rivaroxaban

Project Status:

Complete

Therapeutic Area:

Atrial fibrillation, stroke prevention

Manufacturer:

Bayer Inc.

Call for patient/clinician input open:

October 18, 2011

Brand Name:

Xarelto

Project Line:

Reimbursement Review

Project Number:

SR0257-000

Call for patient/clinician input closed:

November 9, 2011

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Atrial fibrillation, stroke prevention

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 19, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 21, 2011